CX 2018: Ulf Teichgräber discusses EffPAC trial 12-month results

1327

Ulf Teichgräber, Jena, Germany, discusses the EffPAC trial 12-month results which were presented for the first time at CX 2018


LEAVE A REPLY

Please enter your comment!
Please enter your name here